| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |